AR223716A1 - Procedimiento para producir 3-hidroxi-5-(4-piridinil)-2(1h)-piridinona - Google Patents

Procedimiento para producir 3-hidroxi-5-(4-piridinil)-2(1h)-piridinona

Info

Publication number
AR223716A1
AR223716A1 AR281876A AR28187680A AR223716A1 AR 223716 A1 AR223716 A1 AR 223716A1 AR 281876 A AR281876 A AR 281876A AR 28187680 A AR28187680 A AR 28187680A AR 223716 A1 AR223716 A1 AR 223716A1
Authority
AR
Argentina
Prior art keywords
piridinone
piridinil
hydroxy
procedure
produce
Prior art date
Application number
AR281876A
Other languages
English (en)
Spanish (es)
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Application granted granted Critical
Publication of AR223716A1 publication Critical patent/AR223716A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/69Two or more oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AR281876A 1979-09-10 1980-07-23 Procedimiento para producir 3-hidroxi-5-(4-piridinil)-2(1h)-piridinona AR223716A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/073,885 US4225601A (en) 1979-09-10 1979-09-10 3-Hydroxy or hydroxymethyl-5-(4-pyridinyl)2(1H)-pyridinones, useful as cardiotonic agents and their preparation

Publications (1)

Publication Number Publication Date
AR223716A1 true AR223716A1 (es) 1981-09-15

Family

ID=22116385

Family Applications (1)

Application Number Title Priority Date Filing Date
AR281876A AR223716A1 (es) 1979-09-10 1980-07-23 Procedimiento para producir 3-hidroxi-5-(4-piridinil)-2(1h)-piridinona

Country Status (21)

Country Link
US (1) US4225601A (da)
JP (1) JPS5668670A (da)
KR (1) KR830003470A (da)
AR (1) AR223716A1 (da)
AU (1) AU6003080A (da)
BE (1) BE884329A (da)
DE (1) DE3027901A1 (da)
DK (1) DK314180A (da)
ES (1) ES493583A0 (da)
FI (1) FI802298A7 (da)
FR (1) FR2465722A1 (da)
GB (1) GB2058751A (da)
IL (1) IL60360A0 (da)
IT (1) IT1132192B (da)
LU (1) LU82650A1 (da)
NL (1) NL8004126A (da)
NO (1) NO802138L (da)
NZ (1) NZ194106A (da)
PT (1) PT71427A (da)
SE (1) SE8004934L (da)
ZA (1) ZA803679B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361569A (en) * 1981-08-26 1982-11-30 Sterling Drug Inc. 3-(Hydroxy or hydroxymethyl)-6-methyl-5-(4-pyridinyl)-2(1H)-pyridinone and cardiotonic use thereof
US4432979A (en) * 1981-10-26 1984-02-21 William H. Rorer, Inc. Pyridone compounds
US4463008A (en) * 1982-11-10 1984-07-31 Sterling Drug Inc. 2-Alkoxy-5-(pyridinyl)pyridines and cardiotonic use thereof
US6068581A (en) * 1998-04-29 2000-05-30 Timm Medical Technologies, Inc. Method and apparatus for testing and exercising pelvic muscles
JP5860417B2 (ja) * 2010-03-04 2016-02-16 メルク・シャープ・エンド・ドーム・コーポレイション カテコールo−メチルトランスフェラーゼの阻害剤および精神障害の治療におけるその使用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4072746A (en) * 1975-10-14 1978-02-07 Sterling Drug Inc. 3-Amino-5-(pyridinyl)-2(1H)-pyridinones

Also Published As

Publication number Publication date
NL8004126A (nl) 1981-03-12
BE884329A (fr) 1981-01-16
FI802298A7 (fi) 1981-01-01
IT1132192B (it) 1986-06-25
JPS5668670A (en) 1981-06-09
IL60360A0 (en) 1980-09-16
DK314180A (da) 1981-03-11
PT71427A (en) 1980-07-01
LU82650A1 (fr) 1981-03-24
US4225601A (en) 1980-09-30
NO802138L (no) 1981-03-11
GB2058751A (en) 1981-04-15
ES8106514A1 (es) 1981-07-01
IT8023422A0 (it) 1980-07-14
NZ194106A (en) 1982-03-30
FR2465722A1 (fr) 1981-03-27
DE3027901A1 (de) 1981-03-26
KR830003470A (ko) 1983-06-20
SE8004934L (sv) 1981-03-11
ES493583A0 (es) 1981-07-01
AU6003080A (en) 1981-03-19
ZA803679B (en) 1981-06-24

Similar Documents

Publication Publication Date Title
MX156155A (es) Procedimiento para preparar copoliesteres formadores de fibras
MX156154A (es) Procedimiento para preparar copoliesteres formadores de fibras
AR229081A1 (es) Procedimiento para preparar nuevas mercaptoacilprolinas
AR224502A1 (es) Procedimiento para preparar polivinilbutiral de propiedades mejoradas
MX155904A (es) Procedimiento para preparar una 2(1h)-piridiona
ES496713A0 (es) Procedimiento para preparar alfa-aril-in-imidazol-1-etanoles
AR230995A1 (es) Procedimiento para producir n-fosfono-metilglicina
BR8001029A (pt) Processo para produzir alimentos contendo bifidobacterias
MX156216A (es) Procedimento para preparar copoliesteres formadores de fibras
BR8001988A (pt) Prensa para passar
ES490122A0 (es) Procedimiento para preparar piranonas 5-sustituidas
ES491196A0 (es) Procedimiento para preparar nuevas antraceno-9, 10-bis-car- bonilhidrazonas
AR226704A1 (es) Procedimiento para preparar 6-piridinil-3(2h)-piridacinonas
BR7802499A (pt) Processo para produzir beta-l-frutofuranosil alfa-l-glucopiranosidio
AR219792A1 (es) Procedimiento para preparar s-haloalquenil diisoalquiltiocarbamatos
ES490121A0 (es) Procedimiento para preparar piranonas 6-sustituidas
AR225318A1 (es) Procedimiento para preparar fenil-propil-morfolinas sustituidas
ES488507A0 (es) Procedimiento para identificar documentos
MX5351E (es) Procedimiento para preparar 4-alquiltio-2-trifluorometilalcansulfonanilidas
AR227884A1 (es) Procedimiento para la obtencion de acido(fenil-2-benzotiazolil-6)-2-propionico
ES506016A0 (es) Procedimiento para determinar la desoxirribonucleasa b
BR7805689A (pt) Transmissao para servo-direcao
BR7802193A (pt) Processo para preparacao de amidinas fosforiladas
ES491339A0 (es) Procedimiento para reforzar vellones
MX5559E (es) Procedimiento para preparar tetrahidro-s-triazin-2-(1h)-tionas